Epstein Barr Virus

Epstein-Barr virus, frequently referred to as EBV, is a member of the herpesvirus family and one of the most common human viruses. The virus occurs worldwide, and most people become infected with EBV sometime during their lives.
Multiple Sclerosis and the Epstein Barr Virus

Epstein-Barr virus (EBV) is a herpes virus otherwise known of as human herpesvirus 4 (HHV-4). It is most well known for causing glandular fever but research shows that EBV infection is also linked to an increased risk for various autoimmune conditions including rheumatoid arthritis, dermatomyositis and multiple sclerosis.

Read More

Overview

Latest Epstein Barr Virus News and Research

Coronavirus deranges the immune system in complex and deadly ways

Coronavirus deranges the immune system in complex and deadly ways

Novel dual-targeting drug could become a next-generation treatment for EBV-related cancers

Novel dual-targeting drug could become a next-generation treatment for EBV-related cancers

Both mRNA vaccines protect against emerging variants of SARS-CoV-2

Both mRNA vaccines protect against emerging variants of SARS-CoV-2

Wistar researchers discover new enzymatic function of the Epstein-Barr Virus protein

Wistar researchers discover new enzymatic function of the Epstein-Barr Virus protein

Study examines risk factors for developing ME/CFS in college students after infectious mononucleosis

Study examines risk factors for developing ME/CFS in college students after infectious mononucleosis

COVID-19 has transformed the world of vaccines

COVID-19 has transformed the world of vaccines

Researchers design armored immune cells to attack recurring cancer in liver transplant patients

Researchers design armored immune cells to attack recurring cancer in liver transplant patients

Moderna to develop three new mRNA-based vaccines against HIV, influenza, and the Nipah virus

Moderna to develop three new mRNA-based vaccines against HIV, influenza, and the Nipah virus

Specific genetic target could help explain the variation in COVID-19 effects

Specific genetic target could help explain the variation in COVID-19 effects

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Pomegranate extract could inhibit the virus that causes COVID-19

Pomegranate extract could inhibit the virus that causes COVID-19

Researchers identify effective way to protect vulnerable people from COVID-19

Researchers identify effective way to protect vulnerable people from COVID-19

Study shows how genetic predisposition contributes to the development of multiple sclerosis

Study shows how genetic predisposition contributes to the development of multiple sclerosis

A new therapeutic approach for Epstein-Barr virus-associated tumors

A new therapeutic approach for Epstein-Barr virus-associated tumors

Case report of arthritis in a COVID-19 patient

Case report of arthritis in a COVID-19 patient

Discovery of high affinity binders for SARS-CoV-2 spike protein

Discovery of high affinity binders for SARS-CoV-2 spike protein

Discovering a molecule that could interfere with SARS-CoV-2 replication

Discovering a molecule that could interfere with SARS-CoV-2 replication

Spike ferritin nanoparticles show potential as SARS-CoV-2 vaccine

Spike ferritin nanoparticles show potential as SARS-CoV-2 vaccine

COVID-19 could compromise key element of immune response

COVID-19 could compromise key element of immune response

COVID-19 virus acts as a 'sponge' to deplete specific host microRNAs

COVID-19 virus acts as a 'sponge' to deplete specific host microRNAs